According to Hardman&Co....14 Aug 2018 10:29
estimates we should all be considerably better off by 2020, pending successful progress of partners' clinical trials of course! so any huge sell off and large declines in sp could signal failures in any one or more of the trials. I would argue that we are not seeing that despite directors exercising some of their options. I truly believe this company will get there, been invested for quite some years so not about to throw the towel in now! just my opinion and not a ramp by any means.